Works matching AU Hajazimian, Saba

Results: 13

Anti-inflammatory activity of emu oil-based nanofibrous scaffold through downregulation of IL-1, IL-6, and TNF-α pro-inflammatory cytokines.

Published in:

Hormone Molecular Biology & Clinical Investigation, 2020, v. 41, n. 2, p. 1, doi. 10.1515/hmbci-2019-0052

By:

Vahedian, Vahid;
Asadi, Amirhooman;
Esmaeili, Parisa;
Zamani, Shahbaz;
Zamani, Reza;
Hajazimian, Saba;
Isazadeh, Alireza;
Shanehbandi, Dariush;
Maroufi, Nazila Fathi

Publication type:

Article

Analysis of cervical lesions for presence of HSV-2 and HPV-16 and HPV-18 in Iranian patients by PCR.

Published in:

Hormone Molecular Biology & Clinical Investigation, 2017, v. 31, n. 3, p. 1, doi. 10.1515/hmbci-2017-0019

By:

Ahmadi, Mahsa;
Rasi, Hossien;
Mostafazadeh, Mostafa;
Hajazimian, Saba;
Maroufi, Nazila Fathi;
Nahaei, Mohammad Reza;
Rahaee, Shiva;
Isazadeh, Alireza

Publication type:

Article

Inhibition of Colorectal Cancer Cell Line CaCo-2 by Essential Oil of Eucalyptus camaldulensis Through Induction of Apoptosis.

Published in:

Acta Medica Iranica, 2020, v. 58, n. 6, p. 260

By:

Taheri, Elham;
Ghorbani, Saba;
Safi, Maryam;
Sani, Nasrin Seyyed;
Amoodizaj, Fatemeh Firouzi;
Heidari, Masoud;
Chavoshi, Reza;
Hajazimian, Saba;
Isazadeh, Alireza;
Heidari, Mansour

Publication type:

Article

A Novel Homozygous MYO7A Mutation: Case Report.

Published in:

2018

By:

Ahmadi, Mahsa;
Dehghanifard, Ali;
Isazadeh, Alireza;
Hajazimian, Saba;
Mehdizadeh, Mahshad;
Rahaei, Shiva;
Hosseini, Soudabeh;
Kalantari, Ebrahim

Publication type:

Case Study

Identification of a compound heterozygous missense mutation in LAMA2 gene from a patient with merosin‐deficient congenital muscular dystrophy type 1A.

Published in:

Journal of Clinical Laboratory Analysis, 2021, v. 35, n. 11, p. 1, doi. 10.1002/jcla.23930

By:

Khorrami, Afshin;
Goleij, Pouya;
Karamad, Vahidreza;
Taheri, Elham;
Shadman, Behrouz;
Emami, Parisa;
Jahangirzadeh, Gholamreza;
Hajazimian, Saba;
Isazadeh, Alireza;
Baradaran, Behzad;
Heidari, Mansour

Publication type:

Article

Melatonin increases the anticancer potential of doxorubicin in Caco‐2 colorectal cancer cells.

Published in:

Environmental Toxicology, 2021, v. 36, n. 6, p. 1061, doi. 10.1002/tox.23105

By:

Jadid, Mahdieh Farhoudi Sefidan;
Aghaei, Elnaz;
Taheri, Elham;
Seyyedsani, Nasrin;
Chavoshi, Reza;
Abbasi, Samane;
Khorrami, Afshin;
Goleij, Pouya;
Hajazimian, Saba;
Taefehshokr, Sina;
Isazadeh, Alireza;
Shanehbandi, Dariush

Publication type:

Article

Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA‐PAA nano‐encapsulation on PANC‐1 pancreatic cancer cell line.

Published in:

Environmental Toxicology, 2021, v. 36, n. 6, p. 1043, doi. 10.1002/tox.23103

By:

Jadid, Mahdieh Farhoudi Sefidan;
Shademan, Behrouz;
Chavoshi, Reza;
Seyyedsani, Nasrin;
Aghaei, Elnaz;
Taheri, Elham;
Goleij, Pouya;
Hajazimian, Saba;
Karamad, Vahidreza;
Behroozi, Javad;
Sabet, Mehrdad Nasrollahzadeh;
Isazadeh, Alireza;
Baradaran, Behzad

Publication type:

Article

Association of rs1946518 C/A Polymorphism in Promoter Region of Interleukin 18 Gene and Breast Cancer Risk in Iranian Women: A Case-control Study.

Published in:

Iranian Journal of Allergy, Asthma & Immunology, 2019, v. 18, n. 6, p. 671

By:

Maroufi, Nazila Fathi;
Aghayi, Elnaz;
Garshasbi, Hamid;
Matin, Milad Gholampour;
Bedoustani, Ahmad Babazadeh;
Amoudizaj, Fatemeh Firouzi;
Hajazimian, Saba;
Isazadeh, Alireza;
Taefehshokr, Sina;
Taefehshokr, Nima;
Baradaran, Behzad

Publication type:

Article

Prevalence of Chromosomal Abnormalities in Iranian Patients with Infertility.

Published in:

Archives of Iranian Medicine (AIM), 2023, v. 26, n. 2, p. 110, doi. 10.34172/aim.2023.17

By:

Abbaspour, Saima;
Isazadeh, Alireza;
Heidari, Matin;
Heidari, Masoud;
Hajazimian, Saba;
Soleyman-Nejad, Morteza;
Taskhiri, Mohammad Hossein;
Bolhassani, Manzar;
Ebrahimi, Amir Hossein;
Keshavarz, Parvaneh;
Shiri, Zahra;
Heidari, Mansour

Publication type:

Article

Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma.

Published in:

Journal of Biochemical & Molecular Toxicology, 2020, v. 34, n. 6, p. 1, doi. 10.1002/jbt.22486

By:

Firouzi Amoodizaj, Fatemeh;
Baghaeifar, Sevda;
Taheri, Elham;
Farhoudi Sefidan Jadid, Mahdieh;
Safi, Maryam;
Seyyed Sani, Nasrin;
Hajazimian, Saba;
Isazadeh, Alireza;
Shanehbandi, Dariush

Publication type:

Article

Chimeric antigen receptor T (CAR‐T) cells: Novel cell therapy for hematological malignancies.

Published in:

Cancer Medicine, 2023, v. 12, n. 7, p. 7844, doi. 10.1002/cam4.5551

By:

Abbasi, Samane;
Totmaj, Milad Asghari;
Abbasi, Masoumeh;
Hajazimian, Saba;
Goleij, Pouya;
Behroozi, Javad;
Shademan, Behrouz;
Isazadeh, Alireza;
Baradaran, Behzad

Publication type:

Article

Resistance mechanisms to immune checkpoints blockade by monoclonal antibody drugs in cancer immunotherapy: Focus on myeloma.

Published in:

Journal of Cellular Physiology, 2021, v. 236, n. 2, p. 791, doi. 10.1002/jcp.29905

By:

Isazadeh, Alireza;
Hajazimian, Saba;
Garshasbi, Hamid;
Shadman, Behrouz;
Baghbanzadeh, Amir;
Chavoshi, Reza;
Taefehshokr, Sina;
Farhoudi Sefidan Jadid, Mahdieh;
Hajiasgharzadeh, Khalil;
Baradaran, Behzad

Publication type:

Article

Potential Therapeutic Effects of Melatonin Mediate via miRNAs in Cancer.

Published in:

Biochemical Genetics, 2022, v. 60, n. 1, p. 1, doi. 10.1007/s10528-021-10104-4

By:

Pourmohammad, Pirouz;
Maroufi, Nazila Fathi;
Rashidi, Mohsen;
Vahedian, Vahid;
Pouremamali, Farhad;
Faridvand, Yousef;
Ghaffari-novin, Mahsa;
Isazadeh, Alireza;
Hajazimian, Saba;
Nejabati, Hamid Reza;
Nouri, Mohammad

Publication type:

Article